| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 37.23 | 1.9% | 8.7% |
| Total Income | 37.23 | 1.9% | 8.7% |
| Expenditure | 43.23 | 11.5% | 33.1% |
| PBT | — | ||
| Net Profit | -6.00 | 650.0% | 435.2% |
| OPM | — | ||
| NPM | -16.12% | 14.01pp | 21.35pp |
| EPS | -0.45 | 4400.0% | 1600.0% |
Global Medical REIT Reports Q3 2025 FFO $1.00 per share and unit
04 May 2026 · 4 May, 8:14 am
Summary
Global Medical REIT Inc. announced its Q3 2025 financial results, reporting a net loss attributable to common stockholders of $6.0 million, or $0.45 per diluted share. FFO increased to $14.5 million, or $1.00 per share and unit, a 4% year-over-year increase. AFFO also increased by 4% year-over-year to $16.2 million, or $1.12 per share and unit. Same-store cash NOI grew by 2.7% year-over-year. The company completed two dispositions during the quarter for $3.8 million.
Key Highlights
- 1
Global Medical REIT's net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share for Q3 2025.
- 2
Funds from operations (FFO) increased to $14.5 million, or $1.00 per share and unit, representing a 4% year-over-year increase on a per share and unit basis.
- 3
Adjusted funds from operations (AFFO) increased to $16.2 million, or $1.12 per share and unit, representing a 4% year-over-year increase on a per share and unit basis.
- 4
Same-store cash net operating income (NOI) growth was 2.7% on a year-over-year basis for the third quarter.
- 5
The company completed the disposition of two facilities during the quarter, receiving aggregate gross proceeds of $3.8 million.
- 6
Portfolio leased occupancy was 95.2% as of September 30, 2025.
- 7
The company amended and restated its credit facility in October 2025, extending the maturities of the revolver and Term Loan A components.
Informational and educational content only. Not investment advice.